Ameritas Investment Company’s ARK Genomic Revolution ETF ARKG Stock Holding History

Ameritas Investment Company’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3.1M	Buy	41,447 +35,699	+621%	+$3M	0.14%	123
2021 Q2	$1.65M	Sell	5,748 -1,744	-23%	-$148K	0.08%	206
2021 Q1	$665K	Buy	7,492 +3,141	+72%	+$312K	0.06%	289
2020 Q4	$406K	Buy	+4,351	New	+$347K	0.08%	255
2020 Q2	–	Sell	-297	Closed	-$9K	–	409
2020 Q1	$9K	Buy	+297	New	+$9.92K	﹤0.01%	1215
2019 Q4	–	Sell	-288	Closed	-$9K	–	881
2019 Q3	$9K	Buy	+288	New	+$9.36K	﹤0.01%	1133
2019 Q1	–	Sell	-4	Closed	–	–	1001
2018 Q4	$0	Buy	+4	New	+$113	﹤0.01%	1513

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameritas Investment Company's ARKG Position: Q3 2021 in Review

Ameritas Investment Company increased its ARK Genomic Revolution ETF (ARKG) stake by 621% in Q3 2021, buying an estimated $3M and bringing the position to 41,447 shares worth $3.1M. The position accounts for 0.14% of the portfolio, ranked #123.

Ameritas Investment Company first reported a position in ARKG in Q4 2018 and has held it in 7 quarters since. 469 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

Ameritas Investment Company held 41,447 shares of ARK Genomic Revolution ETF worth $3.1M as of Q3 2021.
Ameritas Investment Company bought 35,699 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $3M.
ARK Genomic Revolution ETF made up 0.14% of Ameritas Investment Company's portfolio in Q3 2021, its #123 holding.
Ameritas Investment Company first reported a position in ARK Genomic Revolution ETF in Q4 2018 and has held it in 7 quarters since.
469 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.